Real-time enrollment status for this glioblastoma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:06 PM UTC
| NCT Number | NCT03382977 |
| Recruiting Status | Recruiting |
| Condition | Glioblastoma |
| Phase | Clinical Trial |
| Target Enrollment | 98 participants |
| Active Locations | 12 sites in the US |
| Sponsor | VBI Vaccines Inc. |
| Last Updated on CT.gov | March 11, 2025 (Mar 11, 2025) |
As of March 2, 2026: Clinical trial NCT03382977 is currently recruiting participants. This clinical trial study for glioblastoma is actively seeking new participants at 12 locations across the United States. The study is sponsored by VBI Vaccines Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03382977 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03382977 was last updated Mar 11, 2025 (March 11, 2025). HelloStudys verifies this status automatically.